Rare disease medicine approvals
STO-REC-STAT1YQ3S0T1 Official
55
China · 2024
Rare disease medicine approvals in China stood at 55 in 2024 (NMPA).
- Publisher
- NMPA
- Authority tier
- T1 Official
- Locator
- China approves 48 innovative drugs in 2024
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
In addition, the nation also approved 55 rare disease medicines and 106 pediatric medicines.
Verbatim extraction verified: The figure 55 is directly attested in the quoted passage (China approves 48 innovative drugs in 2024).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- National Medical Products Administration. (2024). China approves 48 innovative drugs in 2024. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Via StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY
- MLA
- National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024, https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY.
- Chicago
- National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024. https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY.
- BibTeX
- @misc{nmpa2024rared05aky, author = {{National Medical Products Administration}}, title = {China approves 48 innovative drugs in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY}, note = {Original source: https://english.nmpa.gov.cn/2025-03/19/c\_1079532.htm. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- National Medical Products Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- China approves 48 innovative drugs in 2024
- Type
- Press release
- Published
- —
- Locator
- China approves 48 innovative drugs in 2024
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY